BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a developer of next-generation biopharmaceuticals and pioneer of the...
Zacks Investment Research upgraded shares of iBio (NYSEAMERICAN:IBIO) from a sell rating to a hold rating in a research report released on Monday morning, Zacks.com reports....
Nano cap iBio (IBIO -4.5%) has filed a preliminary prospectus for a public offering of common stock. Price, volume and terms have yet to be announced.Now read: Ritter Pharma...
Ibio Inc (NYSE:IBIO) was one of the more fascinating stocks at the onset of the Covid-19 pandemic. The company already possessed a proprietary system for producing proteins from...
As the world eagerly awaits results for the U.S. Presidential election, there's yet another highly anticipated event: a breakthrough in the coronavirus vaccine.Positive news about...
The COVID-19 pandemic has created several equity market winners, including pharma giant AstraZeneca (LON:AZN) (NYSE:AZN). The company, along with its partner Oxford University, is...
iBio, Inc. is a developer of biopharmaceuticals and FastPharming Manufacturing System. The Company is applying its technologies to develop product candidates to treat or prevent fibrotic diseases, cancers, and infectious diseases. The Company is using its FastPharming Manufacturing System (FastPharming System) and Glycaneering Services to build a portfolio of biologic drug candidates. The Company is also using the FastPharming System to create proteins for others by contract through the Company’s catalog. The Company operates through two segments: Biopharmaceuticals and Bioprocessing. Its Biopharmaceuticals segment, which includes development and licensing in two business units: therapeutics and vaccines. Its Bioprocessing, which includes services and products for research and further manufacturing uses, collectively known as Research & Bioprocess products (RBP). Its pipeline includes IBIO-100, IBIO-101, IBIO-202 and IBIO-400.
Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 396.57 | 405.71 | 380.00 | -111.68 | -21.97% | 30.86M | NASDAQ | |||
| 166.03 | 166.32 | 162.97 | +1.52 | +0.92% | 50.03M | NASDAQ | |||
| 314.08 | 318.28 | 307.78 | -2.48 | -0.78% | 11.62M | NASDAQ | |||
| 2,693.58 | 2,697.31 | 2,643.41 | +27.43 | +1.03% | 1.10M | NASDAQ | |||
| 983.00 | 1,004.55 | 951.50 | -13.27 | -1.33% | 15.77M | NASDAQ | |||
| 2,966.76 | 3,017.97 | 2,900.68 | -66.58 | -2.20% | 3.30M | NASDAQ | |||
| 245.11 | 248.23 | 232.63 | +3.61 | +1.49% | 33.47M | NASDAQ | |||
| 50.46 | 50.98 | 50.39 | +0.13 | +0.26% | 3.23M | NYSE | |||
| 163.67 | 171.25 | 159.14 | -3.85 | -2.30% | 5.49M | NASDAQ | |||
| 6.04 | 6.08 | 5.70 | +0.12 | +2.11% | 12.20M | NASDAQ | |||
| 17.65 | 18.41 | 16.22 | -0.42 | -2.35% | 29.87M | NYSE | |||
| 53.05 | 53.11 | 52.00 | +1.00 | +1.93% | 15.20M | NASDAQ | |||
| 28.32 | 28.99 | 27.23 | -0.81 | -2.78% | 29.19M | NYSE | |||
| 19.68 | 20.06 | 19.50 | -0.23 | -1.18% | 8.83M | NYSE | |||
| 27.70 | 27.80 | 27.07 | -0.51 | -1.81% | 2.72M | NYSE |